Investigating a Novel Sensory-based Program for Veterans With PTSD
SENSE-PTSD
Investigating the Feasibility and Efficacy of a Novel Sensory-based Psychoeducation Program for Military Veterans With Posttraumatic Stress Disorder
1 other identifier
interventional
90
0 countries
N/A
Brief Summary
SENSE-PTSD is an randomized controlled trial (RCT) which will evaluate the feasibility and efficacy of a novel, sensory-based psychoeducational program for improving psychological, functional, sensory, and cognitive outcomes in Canadian military veterans with posttraumatic stress disorder (PTSD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2024
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2022
CompletedFirst Posted
Study publicly available on registry
March 13, 2023
CompletedStudy Start
First participant enrolled
April 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedMarch 12, 2024
March 1, 2024
1.4 years
September 28, 2022
March 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Recruitment rate feasibility
Rate of recruitment per month.
17 weeks
Eligibility criteria feasibility
Percentage of individuals who are deemed eligible to participate in the study out of the total number of individuals who complete the pre-screening survey.
17 weeks
Length of completion of procedures feasibility
Time it takes to complete each study procedure.
17 weeks
Location logistics
Issues that arise as a result of the virtual nature of the study.
17 weeks
Attrition rates
Percentage of participants who drop out of SST.
17 weeks
Attendance rates of program
Percentage of SST sessions attended per participant.
17 weeks
Staff size feasibility
Facilitator feedback about how onerous their workload is.
17 weeks
Communication feasibility
Research team feedback on whether communication between research team members is adequate.
17 weeks
Secondary Outcomes (14)
Sensory difficulties
17 weeks
Occupational performance
17 weeks
PTSD symptomatology (structured interview)
17 weeks
Mental health symptomatology
17 weeks
Depression, anxiety, and stress symptomatology
17 weeks
- +9 more secondary outcomes
Study Arms (2)
Program group
EXPERIMENTALParticipants in this group will receive five weekly sessions of Sensory Strategies Training (SST), facilitated by a trained clinician or graduate/post-graduate student in a health-related field.
Waitlist control group
NO INTERVENTIONParticipants in the waitlist control group will not receive SST or any other PTSD or sensory-processing treatments for the duration of the study.
Interventions
In SST, participants will be introduced to the concept of sensory processing in the context of PTSD and will learn about the ways in which difficulties in this area can impact their affective, cognitive, and functional outcomes. Participants will learn about the effects of PTSD symptoms on their ability to regulate stressful situations and engage in social interactions, as well as the benefits of physical activity and proper sleep hygiene. Participants will also identify functional goals (e.g., reduce sensation-avoiding, better regulate physical and emotional reactions to trauma reminders, increase sensory sensitivity, etc.) which they will aim to achieve with the knowledge and resources gained from SST. Throughout the program, participants will learn various strategies to help with movement, sleep, and interacting with others, and will have opportunities to practice the strategies identified as being relevant to their specific needs during their baseline sensory assessment.
Eligibility Criteria
You may qualify if:
- English-speaking adults between the ages of 18 and 65
- Veterans of the Canadian Armed Forces (active service and/or reservist);
- Meet diagnostic criteria for PTSD on the Clinician Administered PTSD Scale (CAPS-5);
- Able to provide written informed consent;
- Have access to a smart phone, tablet, or computer with a working microphone and camera;
- Have access to consistent and reliable Internet.
You may not qualify if:
- Use benzodiazepines daily or almost daily;
- Use narcotics daily or almost daily;
- Diagnosis of substance use disorder in the past 3 months;
- History of severe head trauma with loss of consciousness or history of traumatic brain injury;
- History of neurological disorder;
- Diagnosis of a psychotic disorder or bipolar disorder;
- Diagnosis of a neurodevelopmental disorder;
- Have not had stable psychiatric medication for 6 months prior to study participation;
- Currently receiving counselling which targets trauma or sensory processing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- McMaster Universitylead
- Veterans Affairs Canadacollaborator
Related Publications (3)
Jackson CE, Ciarleglio MM, Aslan M, Marx BP, Ko J, Concato J, Proctor SP, Vasterling JJ. Associations Among Increases in Posttraumatic Stress Symptoms, Neurocognitive Performance, and Long-Term Functional Outcomes in U.S. Iraq War Veterans. J Trauma Stress. 2021 Jun;34(3):628-640. doi: 10.1002/jts.22663. Epub 2021 Mar 2.
PMID: 33650202BACKGROUNDWatkins LE, Sprang KR, Rothbaum BO. Treating PTSD: A Review of Evidence-Based Psychotherapy Interventions. Front Behav Neurosci. 2018 Nov 2;12:258. doi: 10.3389/fnbeh.2018.00258. eCollection 2018.
PMID: 30450043BACKGROUNDRegier DA, Kuhl EA, Kupfer DJ. The DSM-5: Classification and criteria changes. World Psychiatry. 2013 Jun;12(2):92-8. doi: 10.1002/wps.20050.
PMID: 23737408BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Margaret McKinnon, PhD
McMaster University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 28, 2022
First Posted
March 13, 2023
Study Start
April 1, 2024
Primary Completion
August 31, 2025
Study Completion
August 31, 2025
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share